Related Experiment Video

Updated: Feb 7, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

901

Identification of a Novel BRAF Thr599dup Mutation in Lung Adenocarcinoma

Xuefei Zhang1,2, Mo Li1, Desheng Lv1

  • 1Department of Thoracic Surgery, The Second Hospital of Dalian Medical University, Dalian 116023, China.

Open Medicine (Warsaw, Poland)
|July 19, 2018
PubMed

Insights

A novel BRAF Thr599dup mutation was identified in non-small cell lung cancer (NSCLC). This discovery expands understanding of BRAF gene mutations, crucial for optimizing targeted therapies in NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • BRAF mutations are key drivers in non-small cell lung cancer (NSCLC).
  • BRAF V600E mutations respond to BRAF inhibitors.
  • Identifying novel BRAF mutations is essential for expanding treatment options.

Purpose of the Study:

  • To report the identification and characterization of a novel BRAF Thr599dup gene mutation.
  • To investigate the clinical significance of this new mutation in NSCLC.

Main Methods:

  • Next-generation sequencing (NGS) was used for molecular screening.
  • Analysis of a lung carcinoma sample from an Asian never-smoker.

Main Results:

  • A novel BRAF Thr599dup mutation was identified in exon 15.
  • This mutation involves the insertion of tyrosine between amino acids 599 and 600.
  • No other driver alterations like EGFR or ALK were detected.
  • The mutation's profile is consistent with other BRAF-driven NSCLC.

Conclusions:

  • The BRAF Thr599dup mutation represents a new oncogenic driver in NSCLC.
  • This finding broadens the spectrum of known BRAF mutations.
  • It has significant clinical implications for personalized therapeutic strategies in NSCLC.
Keywords:
BRAF thr599dup gene mutationLung adenocarcinomaNext-generation sequencingTargeted therapy

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.3K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K

Related Concept Videos

Mutations01:39

Mutations

Overview
94.6K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.5K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.2K